Equifax (EFX), What Is Behind The Latest Attention?

Equifax (EFX) just broadened its open banking offering through a tie-up with Mastercard Open Finance, putting consumer-permissioned cash flow data alongside traditional credit files and giving lenders fresh tools for underwriting decisions.

These product launches arrive after a tough stretch for Equifax shareholders, with the share price down 24.66% year to date and the 1 year total shareholder return falling 29.43%. However, a 9.45% 7 day share price gain hints at improving short term momentum.

Scan for more data and analytics players trying to turn complex cash flow and credit files into underwriting edge with our curated list of 20 high quality undiscovered gems.

After a long slide, a US$161.25 share price and a near 62% gap to one intrinsic value estimate pull Equifax into awkward territory. Is this a genuine markdown, or just a value trap in new packaging?

Most Popular Narrative: 21.8% Undervalued

Against a last close of $161.25, the most followed narrative pins Equifax near a $206 fair value, which puts the current quote at a clear discount and turns attention to what might drive that gap to close.

Rapidly growing Work Number records, now at 217 million active records with 108 million unique Social Security numbers, along with high margin Workforce Solutions revenue and 52.1% segment EBITDA margins, are increasing the share of recurring verification income and supporting group level margin expansion.

See why 30 investors see Equifax as 22% undervalued.

Result: Fair Value of $206.33 (UNDERVALUED)

Still, housing policy shifts that pressure mortgage credit report pricing and slower than hoped government verification revenue could easily stall the current Equifax narrative.

Find out about the key risks to this Equifax narrative.

Next Steps

Unsure whether Equifax is a bargain or a potential trap at these levels? Act while the facts are fresh and weigh the mix of 4 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Equifax?

Do not stop your research with Equifax alone. Reviewing a broader context across sectors and styles can provide a clearer sense of where risk and opportunity sit.

• Target potential mispricings and compare quality by scanning our curated set of 33 high quality undervalued stocks that pair fundamentals with current market expectations.
• Strengthen your income playbook by reviewing 8 dividend fortresses that combine higher yields with supporting financial metrics.
• Protect your capital first by focusing on 32 resilient stocks with low risk scores that score well on resilience and balance sheet strength.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com